Cargando…

Efficacy and Safety of Intensified vs Standard Prophylactic Anticoagulation Therapy in Patients Hospitalized With Coronavirus Disease 2019: Updated Systematic Review and Meta-analysis

Detalles Bibliográficos
Autores principales:	Scheier, Thomas C, Carlin, Stephanie, Wills, Nicola K, Wasserman, Sean, Mertz, Dominik, Eikelboom, John W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10633781/ https://www.ncbi.nlm.nih.gov/pubmed/37953813 http://dx.doi.org/10.1093/ofid/ofad506

Ejemplares similares

Efficacy and Safety of Intensified Versus Standard Prophylactic Anticoagulation Therapy in Patients With Coronavirus Disease 2019: A Systematic Review and Meta-Analysis
por: Wills, Nicola K, et al.
Publicado: (2022)

Efficacy and safety of intensified versus standard prophylactic anticoagulation therapy in patients with Covid-19: a systematic review and meta-analysis
por: Wills, Nicola K, et al.
Publicado: (2022)

Standard of care in advanced HIV disease: review of HIV treatment guidelines in six sub-Saharan African countries
por: Scheier, Thomas C., et al.
Publicado: (2023)

High-Dose Prophylactic Anticoagulation in Severe COVID-19 Pneumonia
por: Nadeem, Rashid, et al.
Publicado: (2021)

Clinical Outcomes With the Use of Prophylactic Versus Therapeutic Anticoagulation in Coronavirus Disease 2019
por: Motta, Jishu Kaul, et al.
Publicado: (2020)

Prophylactic anticoagulant therapy for reducing the risk of stroke and other thrombotic events in COVID-19 patients
por: Aghamohammadi, Mehdi, et al.
Publicado: (2020)

Immortal Time Bias in Comparing Late vs Early Intubation in Patients With Coronavirus Disease 2019
por: Hong, Li
Publicado: (2021)

ACT trials: long-term outcomes
por: Eikelboom, John W, et al.
Publicado: (2023)

STANDARD VS HIGH-INTENSITY PROPHYLACTIC ANTICOAGULATION IN COVID-19: A US, CALIFORNIAN RETROSPECTIVE STUDY
por: AHMADI, TAMANA, et al.
Publicado: (2021)

Famotidine and Coronavirus Disease 2019
por: Freedberg, Daniel E., et al.
Publicado: (2021)

Famotidine and Mortality in Coronavirus Disease 2019
por: Sethia, Rahul, et al.
Publicado: (2021)

Asthma and prognosis of coronavirus disease 2019
por: Özdemir, Öner
Publicado: (2022)

Split-dosing of coronavirus disease 2019 vaccines
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

MicroCLOTS pathophysiology in coronavirus disease 2019
por: Renzi, Samuele, et al.
Publicado: (2023)

Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study
por: Rentsch, Christopher T, et al.
Publicado: (2021)

Pneumothorax in 2019 novel coronavirus pneumonia needs to be recognized
por: Li, Wenya, et al.
Publicado: (2020)

Coronavirus disease 2019 presenting with conjunctivitis as the first symptom
por: Casalino, Giuseppe, et al.
Publicado: (2020)

Etoposide for Cytokine Storm Because of Coronavirus Disease 2019
por: Delgado-López, Pedro David, et al.
Publicado: (2021)

Management Issues of Sarcoidosis in the Time of Coronavirus Disease 2019
por: Tana, Claudio, et al.
Publicado: (2021)

Surveillance of endemic human Coronaviruses in Germany, 2019/2020
por: Biere, Barbara, et al.
Publicado: (2021)

What is the Determinant of 2019 Novel Coronavirus Prognosis in Children?
por: Yurttutan, Sadik
Publicado: (2000)

Zinc and Coronavirus Disease 2019: Causal or Casual Association?
por: Khurana, Alkesh Kumar, et al.
Publicado: (2021)

Exacerbation of livedoid vasculopathy after Coronavirus disease 2019
por: Kawabe, Ryoko, et al.
Publicado: (2022)

Quinine as a Malaria Prophylactic
por: Strickland, C.
Publicado: (1943)

A Prophylactic (?) Against Smallpox
por: Biswas, Satya Kinkar
Publicado: (1931)

Prophylactic Use of Arsenic in Malaria
por: McNally, C. J.
Publicado: (1884)

Time to update the Japanese standard population for comparing mortality rates
por: Dhungel, Bibha, et al.
Publicado: (2022)

Prophylactic Anticoagulation in Nephrotic Syndrome
por: Gerstein, Jonathon, et al.
Publicado: (2023)

Durable functional limitation in patients with coronavirus disease-2019 admitted to intensive care and the effect of intermediate-dose vs standard-dose anticoagulation on functional outcomes
Publicado: (2022)

Association between direct-acting oral anticoagulants vs. warfarin with the risk of osteoporosis in patients with non-valvular atrial fibrillation
por: Akhtar, Tauseef, et al.
Publicado: (2020)

Containment strategies for the 2019 Novel Coronavirus: flatten the curve or crush it?
por: Killeen, Gerry
Publicado: (2020)

Myasthenic crisis in the setting of Coronavirus Disease 2019 (COVID-19)
por: Salik, Irim, et al.
Publicado: (2020)

Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs
por: Georgiev, Tsvetoslav
Publicado: (2020)

Diabetic retinopathy screening during the coronavirus disease 2019 pandemic
por: Shih, Kendrick C., et al.
Publicado: (2020)

Airborne transmission of coronavirus disease 2019: a clinician’s perspective
por: Oh, Myoung-don
Publicado: (2021)

The many faces of coronavirus disease 2019: COVID-19 and the liver
por: Almas, Talal, et al.
Publicado: (2021)

Aseptic Meningitis and mRNA Coronavirus Disease 2019 Vaccine
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Venerable but Vulnerable: When Centenarians Encounter Coronavirus Disease 2019
por: Dessemon, Juliette, et al.
Publicado: (2022)

Questioning Tocilizumab Use in Hospitalized Patients With Coronavirus Disease 2019
por: Mombrun, Martin, et al.
Publicado: (2021)

Digital Mentorship in Cardiothoracic Surgery in the Coronavirus Disease 2019 Era
por: Xu, Samantha, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ooatfua2tcjlkate2p0q2srg9g